Service Corporation International: Cemetery Gross Profit Now Exceeds Funeral, but a 6.5% Owner-Earnings Yield Sits Only 1.8 Points Above Treasuries

The funeral side is facing a more durable equation. In 2025, comparable funeral services performed fell 0.8%, while average revenue per service rose 2.9%; cremation mix increased 50 basis points to 64.4%. For the first half of 2026, services performed were down 3.8%, while average revenue per service rose 3.4%, and the cremation rate reached 64.7%, again 50 basis points higher. Comparable first-half funeral gross margin fell to 20.0% from 22.2%, with SCI identifying lower revenue against a relatively fixed cost base and increased selling compensation associated with stronger preneed production as contributors.

The structural funeral equation is unfavorable: case volumes currently decline, cremation keeps shifting the mix toward lower-ticket dispositions, and price must outrun both forces before funeral profit can grow. SCI’s response is sensible. It sells more memorialization around cremation, offers service-rich cremation packages, develops cemetery niches and other cremation inventory, and uses customer-facing technology to create attachment opportunities. The response is working well enough to keep average revenue per service rising roughly 3%, but the current numbers do not show a clean underlying funeral volume-growth engine.

The demographic bull case is real but slower than promotional shorthand implies. The CDC recorded 3.073 million U.S. resident deaths in 2024, down 18,298 from 2023, while 2020 saw approximately 3.359 million deaths during the first pandemic year. Census projections have long shown that deaths should rise as the baby-boom cohort ages; an official Census analysis projected more than 3.6 million annual deaths by 2037 and a rising trend into the middle of the century. The latest Census projection framework still explicitly models annual births, deaths and migration through 2100.

The correct investment interpretation is roughly 1% long-run annual growth in the addressable number of deaths, not a demographic boom. The 2020–2022 excess-mortality period also pulled some deaths that would otherwise have occurred later into an earlier period. The subsequent decline from the pandemic peak is visible in national data and in SCI’s funeral volumes. There is no credible public dataset that lets an investor cleanly allocate each percentage point of SCI’s 2025–2026 volume weakness between mortality pull-forward, local market share, ordinary seasonal mortality, and mix, so any precise decomposition would be false precision. The evidence does support the idea that post-pandemic normalization is material and that the underlying demographic trend should eventually become positive again.

The cemetery business is different. In 2025 SCI generated 1.904 billion USD of cemetery revenue and 644 million USD of cemetery gross profit, a 33.8% gross margin, compared with funeral revenue of 2.406 billion USD and gross profit of 496 million USD. Roughly 896 million USD of cemetery revenue came from recognition of preneed property sales, another 422 million USD from preneed merchandise and services, and only about 436 million USD from atneed cemetery activity. Cemetery economics are therefore substantially driven by selling developed property and future merchandise before death.

SCI spent 1.421 billion USD on cemetery preneed sales production in 2025; about 1.014 billion USD of cemetery sales was deferred into backlog while 799 million USD of previously deferred revenue emerged from backlog. The 2026 capital plan calls for about 170 million USD of cemetery property development, versus 140 million USD of improvements at existing field locations and 25 million USD of digital/corporate investment. Cemetery property is a recurring capital requirement, not a cosmetic capex line.

Management has separately said its aggregate cemetery inventory spans more than a century. That substantially reduces the risk that SCI as a whole simply “runs out of land,” although the aggregate figure can hide a different problem: the highest-demand gardens, mausoleums, niches and specific metropolitan cemetery locations still require continual development and repricing. An acre of undeveloped land at a low-demand cemetery is not interchangeable with premium developed inventory at a constrained metropolitan property.

The competitive position is unusually strong at the corporate level and less dominant at the customer interface. SCI has 1,495 funeral service locations and 505 cemeteries, including 316 combination locations, as of June 30, 2026. Scale allows local clusters to share vehicles, preparation facilities, personnel, marketing systems, procurement and back-office infrastructure. Its multi-billion-dollar trusts can hire managers and negotiate fees at a scale unavailable to a single family funeral home. Its preneed sales apparatus and digital lead generation are difficult to duplicate locally.

Scale is a real operating moat, but the funeral purchase itself remains stubbornly local. A family often selects a funeral home because of location, prior family experience, a particular funeral director, religious or community relationships, or a local heritage name. SCI’s continued use of local identities under the Dignity Memorial umbrella reflects that reality. National scale reduces cost and improves selling capacity; it does not turn the customer decision into a winner-take-all branded network.

The market currently trades SCI as a defensive cash compounder rather than as a pure funeral-volume play. At 83.36 USD, the stock trades at roughly 19.8 times the midpoint of 2026 adjusted EPS guidance. Its trailing P/E is around 21.5–21.8 times, versus one data series’ 10-year average of about 17.6 times. The market therefore gives SCI a material premium to its own longer history.

Cash-based valuation softens that conclusion. Management’s 1.085 billion USD adjusted operating cash-flow midpoint less 335 million USD of planned maintenance, cemetery-development and digital/corporate capex gives roughly 750 million USD of adjusted post-capex cash flow. Against current equity value that is around a 6½% yield. Because cemetery property development is essential to keeping the cemetery sales machine supplied, I deduct the whole 335 million USD rather than pretending that most of it is discretionary “growth capex.”

The qualitative portrait is therefore mature cash cow, with compounding characteristics. SCI has a durable local-services franchise, unusually valuable preneed infrastructure, long-lived cemetery assets, recurring cash generation and a proven willingness to shrink its share count. Growth is nevertheless partly manufactured through price, preneed production, acquisitions, trust returns and buybacks because funeral volume itself is not currently growing.

The central bull/bear disagreement is correspondingly narrow. Bulls see the post-pandemic death trough ending, cemetery preneed compounding, a 17.6 billion USD future-revenue reservoir, disciplined buybacks and eventual baby-boomer mortality. Bears see a 20-times-earnings company whose fundamental death-count growth is about 1%, whose lower-ticket cremation mix rises continuously, whose trust-funded economics have meaningful financial-market exposure, and whose leverage is already close to management’s preferred upper range.

Both sides are partly right. The investment problem is deciding how much multiple to pay for management’s ability to bridge that gap.

Vertical history, financial evolution, and valuation history

SCI began in Houston in 1962 under Robert L. Waltrip, a funeral director who had grown up in his family’s funeral business. His insight was organizational rather than technological: individual funeral homes were intensely local, but ownership, purchasing, capital and administrative functions did not have to be. SCI became a vehicle for acquiring and operating multiple funeral businesses while preserving many local identities. The company’s own history dates its founding to 1962; contemporary historical coverage records that it went public in 1969.

Reliable publicly accessible material in this research session did not establish the original 1969 offer price or gross IPO proceeds to a standard I would be willing to publish as fact. The historical record clearly establishes the public-company transition; the original deal economics remain a research blind spot. SCI today has a single primary NYSE common-stock listing under SCI, with no public takeover or delisting process evident in its current SEC and investor-relations stream as of the research date.

The first long stage was proving that a fragmented local industry could be consolidated. The early model was acquisition-led: buy funeral homes and cemeteries, preserve community relationships, and add corporate scale above them. The logic was especially compelling in dense metropolitan clusters, where preparation services, vehicles, labor and management could be shared. That cluster logic survives today; SCI’s filings still describe common resources being shared across local markets.

The second stage pushed the idea too far. During the 1990s SCI transformed from a U.S. consolidator into a global roll-up. By the end of 1999 its network exceeded 4,500 funeral service locations, cemeteries and crematories in more than 20 countries. That scale was extraordinary, but it made the business more financially and operationally complex just as acquisition leverage and market expectations were becoming harder to sustain.

This period left the most important negative lesson in SCI’s history: deathcare demand may be defensive, but a debt-financed consolidator is not automatically financially defensive. The late-1990s/early-2000s retrenchment forced SCI to simplify, sell non-core and international assets, reduce leverage and rebuild around the U.S. and Canada. The company also suspended its dividend around that era; the regular quarterly dividend was restarted in 2005 and has subsequently become an embedded part of capital allocation.

The third stage was therefore balance-sheet repair and geographic refocusing. That reset made the modern company possible. SCI gradually abandoned the idea that the highest-value future lay in operating the maximum number of establishments across the maximum number of countries. It instead became a North American scale platform with a much more coherent field network.

The fourth stage resumed consolidation, but within that narrower model. The 2006 Alderwoods combination and the 2013 Stewart Enterprises transaction removed two of the few operators that approached SCI’s scale. The FTC’s continued attention to funeral-market consolidation illustrates an important point: antitrust analysis in this business is local, because families typically buy funeral and cemetery services within a limited geographic market. The FTC’s Funeral Rule page still lists the SCI/Stewart matter among its significant funeral-industry cases.

That local antitrust logic is an indirect confirmation of SCI’s moat and its limitation. A national market-share number can understate SCI’s power in a particular metropolitan cluster, while overstating its relevance in a town where a family-owned operator has the stronger heritage franchise. SCI can be simultaneously the clear national leader and one of several plausible local choices.

The fifth stage, from roughly the middle of the 2010s through 2019, was less about transformational M&A and more about harvesting the platform. Capital went toward targeted acquisitions, cemetery development, new builds, dividends and sustained buybacks. The business entered the pandemic with a more concentrated North American footprint and a more deliberate leverage framework.

COVID-19 then created the strangest stage in SCI’s public history. U.S. deaths jumped to approximately 3.359 million in 2020, versus a much lower pre-pandemic baseline, and remained elevated into 2021–2022. SCI’s funeral volumes and earnings benefited from an event that was both economically positive for the company and socially catastrophic.

The market eventually understood that the pandemic represented a temporary mortality shock rather than a new permanent death-rate level. By 2023 U.S. deaths had fallen to about 3.091 million and by 2024 to 3.073 million. The current funeral-volume weakness has to be read against that normalization.

The post-pandemic stage has pushed cemetery preneed, trust economics and capital deployment to the center of the story. SCI ended 2025 with 1,485 funeral service locations and 500 cemeteries; by June 2026 the network was 1,495 funeral locations and 505 cemeteries. The funeral establishment count has changed little over several years because acquisitions, divestitures, closures and new builds offset each other. The cemetery network has expanded gradually, and cemetery economics have become the stronger growth engine.

A revealing capital-allocation datapoint came in 2025. SCI spent 101 million USD acquiring 22 funeral homes and two cemeteries and approximately 79 million USD on real estate, new construction and facility expansion. Those numbers show that current M&A is mainly a stream of tuck-ins rather than another Stewart-sized roll-up.

The company does not provide enough purchase-price EBITDA data for ordinary acquisitions to calculate a defensible average acquisition multiple. Dividing aggregate purchase consideration by locations acquired would produce a meaningless “price per location” because the underlying mix of revenue, real estate, trust assets, local market position and cemetery acreage differs. The right conclusion is that the acquisition runway is still physically large but the observed price discipline cannot be independently verified transaction by transaction.

The cash-flow history is more instructive than the net-income history. In 2019 operating cash flow was 628.8 million USD. By 2023 it was 869.0 million USD, by 2024 944.9 million USD and in 2025 942.8 million USD. Capital expenditure simultaneously climbed from a business that already required substantial recurring property investment to 389 million USD in 2025.

Sources and author calculations from SCI filings and earnings materials.

The table shows why the pandemic should not be used as the baseline for forward earnings. Revenue rose sharply versus 2019 and retained most of that step-up even as mortality normalized, which means price, cemetery, preneed, acquisitions and trust economics have replaced part of the temporary volume windfall. Operating cash flow has also remained structurally above its pre-pandemic level.

Earnings quality is therefore better than the falling funeral-volume line suggests, but cash flow is not identical to “owner earnings.” Preneed receipts can increase current operating cash flow while increasing future contractual obligations. Conversely, SCI can incur current selling costs for contracts whose associated funeral revenue will arrive many years later. Cash conversion has to be interpreted over several years, not quarter by quarter.

Using the five-year period through 2025, aggregate operating cash flow was approximately one and a half times aggregate net income. The ratio reflects real cash generation, depreciation and other noncash expenses, but also SCI’s distinctive preneed cash timing. In 2025 alone OCF of 942.8 million USD was 1.74 times net income of 542.8 million USD.

The balance sheet is more leveraged than the “defensive” label might imply. SCI’s targeted leverage is 3.5–4.0 times; at June 30, 2026 it was 3.77 times. The bank covenant limit was 5.0 times, and the company had 1.384 billion USD of borrowing capacity. About 77% of debt was fixed-rate, with a weighted-average rate of 4.84%.

Major scheduled notes include approximately 137 million USD of 7.5% debt due April 2027 and 550 million USD of 4.625% debt due December 2027, followed by 750 million USD due in 2029, 850 million USD in 2030 and 800 million USD in 2031. With the 10-year Treasury around 4.7% at the research date, refinancing no longer occurs against the near-zero-rate environment that supported valuation multiples earlier in the decade.

Share count is an important part of the vertical story. Diluted weighted shares for H1 2026 were 139.1 million versus 144.1 million a year earlier, a decline of about 3.5%. SCI spent 264.9 million USD buying 3.35 million shares during the first half at an average of 79.04 USD and another 25.6 million USD after June 30 at an average 78.22 USD. Those prices sit below the August 28 close of 83.36 USD, although the discount was modest rather than extraordinary.

The June repurchase authorization is worth correcting explicitly. SCI’s board increased authorized repurchases by approximately 472 million USD on June 11, 2026. Together with roughly 128 million USD then remaining, that created 600 million USD of total authority. The subsequent 10-Q reported 567.5 million USD still available at June 30 after actual repurchases. I use the 472 million USD increase and 600 million USD total authority from the company/SEC disclosure. The syndicated “6.38 billion USD authorization” cited in some secondary coverage is an order-of-magnitude error and is rejected.

At today’s market capitalization, the original 600 million USD authority represented roughly 5.2% of equity value. It is meaningful, but it is neither transformative nor evidence that all 5.2% will actually be retired: the authorization is discretionary and competes with acquisitions, development capex, dividends and leverage management.

Valuation has changed with perceived business quality. The stock spent much of the earlier post-crisis era at lower absolute prices and generally lower earnings multiples. A historical valuation series places SCI’s current P/E around 21.5 times versus a 10-year average of approximately 17.6 times, a 22% premium. Another long-history series produces a slightly higher 10-year average of about 18.7 times, but reaches the same direction: today’s accounting-earnings multiple sits above the normal center of the last decade.

The multiple expansion is not pure speculation. SCI today has a more coherent North American footprint than the late-1990s global roll-up, a much larger preneed franchise, established capital-return habits and an unusually valuable cemetery portfolio. What has changed less favorably is the interest-rate alternative: a Treasury security yielding around 4.7% sets a materially higher hurdle than investors faced during much of the 2010s and early 2020s.

Business model, moat, industry, and cycle

SCI reports two operating segments, funeral and cemetery, but economically the company contains at least four different businesses: atneed funeral service, preneed funeral financing/sales, cemetery property development and sales, and management of trust-backed contractual economics.

The 2025 segment split shows why cemetery deserves equal analytical weight.

Author calculations from SCI’s FY2025 segment disclosures.

Funeral is the larger revenue segment. Cemetery is already the larger gross-profit segment. That inversion explains why falling funeral volumes have not translated into equally weak consolidated earnings.

Funeral revenue still depends on the number of deaths, the share of those deaths served by SCI, the average ticket and disposition mix. Traditional burial carries a higher average revenue than cremation, so an increasing cremation rate mechanically pushes against the average ticket unless families buy memorial services, upgraded urns, niches, scattering products, cemetery property or other memorialization. SCI explicitly identifies mix between traditional and cremation services as a driver of average funeral revenue and is building products around cremation to mitigate the gap.

The company’s own recent operating data quantify the challenge. In 2025 services performed declined 0.8%, average revenue per service increased 2.9%, and cremation rose 50 basis points. In H1 2026 services fell 3.8%, average revenue increased 3.4%, and cremation increased another 50 basis points. Q2 improved sequentially in the sense that volume was only down 1.4%, while average revenue per service rose 3.3%.

The national cremation trend is much larger than a one-year fluctuation. The National Funeral Directors Association projected the U.S. cremation rate at 63.4% for 2025 and 82.3% by 2045. SCI’s comparable rate of 64.8% is already broadly consistent with a predominantly cremation market.

The resulting investor test is straightforward. SCI does not need to stop cremation. It needs the dollar value of cremation-related memorialization, services and cemetery products to rise quickly enough that revenue per death keeps compounding. The recent 3%–3½% increase in funeral revenue per service says the offset is currently working at the revenue level. H1 2026’s margin contraction says it is not yet fully working at the profit level.

Cemetery has different physics. SCI buys or already owns land, develops that land into lots, lawn crypts, mausoleum spaces, niches and other memorialization property, then sells interment rights. Accounting recognizes cemetery property revenue when the relevant property is constructed, available for interment and control has transferred under the contract. Undeveloped land and construction in progress therefore form a productive inventory base.

That makes cemetery capital intensity easy to underestimate. The land may have been acquired decades ago, but high-value sellable inventory still requires roads, gardens, drainage, mausoleums, niches and other development. SCI’s 170 million USD 2026 cemetery-development budget is approximately 9% of 2025 cemetery revenue. Treating the entire amount as optional growth capex would flatter owner earnings.

The aggregate inventory position is nevertheless attractive. Management has described average cemetery inventory as extending beyond 100 years. This is closer to a long-duration real-estate reserve than to conventional retail inventory. The economic scarcity is local rather than corporate-wide: a premium metropolitan cemetery with limited developed inventory can be scarce even though the group has a century of aggregate acreage elsewhere.

A precise funeral-versus-cemetery ROIC is not disclosed. The company reports segment revenue, gross profit and assets, while shared corporate costs, financing, taxes, trust-backed liabilities and capital employed are not allocated in a way that produces a clean after-tax segment ROIC. Reporting a highly precise number would therefore create false accuracy.

A useful economic proxy is still possible. Funeral generated roughly 496 million USD of 2025 gross profit on a business with less property-development intensity; cemetery generated 644 million USD but requires a much larger base of cemetery property, trust-related balances and perpetual-care infrastructure. Both also carry contract liabilities that finance part of their asset bases. On a gross return against reported segment assets, the two businesses are in the mid-single digits; after recognizing that several billion dollars of trust-backed assets are matched by customer-related deferred balances rather than shareholder capital, the effective return on net corporate capital is materially higher. The important distinction is that funeral returns rely more on asset-light local-service throughput, while cemetery returns rely on monetizing land and developed inventory over very long periods.

The preneed system connects the two.

The preneed backlog is a liability-shaped earning engine, not an order book.

At June 30, 2026 SCI reported 17.62 billion USD of backlog: 8.64 billion USD trust-funded and 8.98 billion USD insurance- and other-funded. The total consisted of about 5.32 billion USD of cemetery future revenue and 12.30 billion USD of funeral future revenue. Associated assets totaled approximately 17.33 billion USD.

Sources: SCI Q2 Form 10-Q.

The economic ownership can be described in three layers.

First, the contract holder has a protected economic interest. Where law requires trust funding, customer payments are deposited in trusts subject to state or provincial restrictions. SCI cannot treat that cash like ordinary unrestricted corporate cash. Insurance-funded preneed is even clearer: a third-party insurer holds the policy economics and SCI expects to receive insurance proceeds when the contracted service becomes due.

Second, trust investment returns generally help fund the future promised service. SCI’s accounting states that trust earnings identifiable with performance obligations become part of contract consideration and are deferred until the related merchandise or service obligation is satisfied. Those earnings are intended in part to offset the inflation in future costs created by guaranteeing prices years in advance.

Third, shareholders own the residual profit: permitted amounts retained outside trusts, selling/agency economics, any allowable distributions, and ultimately the spread between revenue released from the contract plus eligible investment earnings and the cost of providing the funeral, merchandise or cemetery obligation.

This is why a 17.6 billion USD backlog cannot be capitalized as though it were 17.6 billion USD of ordinary future sales with today’s margin. The duration can run for decades. Customer cancellations and state rules matter. Inflation can raise future fulfillment costs. Investment returns can raise or lower the future economic cushion.

Investment exposure is meaningful. At June 30, 2026 SCI’s preneed trust portfolio had a fair value of about 8.415 billion USD against cost of 6.992 billion USD. U.S. common shares were roughly 2.90 billion USD, equity mutual funds about 1.30 billion USD and equity commingled funds about 0.51 billion USD, before alternatives.

A rough 20% decline across those identified equity buckets alone would erase approximately 940 million USD of trust fair value before considering correlations, hedging, fixed income, alternatives or later market recovery. That would not translate into a 940 million USD immediate shareholder loss: much of the gain/loss is economically associated with customer contracts and deferred balances. The shareholder transmission mechanism is slower and more subtle: less future investment income available when contracts mature, a smaller cushion against the inflation of future service costs, lower perpetual-care distributions, and in certain jurisdictions possible obligations to replenish trust shortfalls. SCI stated that qualifying state-level unrealized losses requiring replenishment were immaterial at year-end 2025, so the present balance sheet does not indicate a current funding crisis.

Trust returns can nevertheless matter greatly to reported growth. SCI recognized 202.2 million USD of preneed trust income and 111.1 million USD of perpetual-care trust income in 2025, 313.3 million USD in total. That was equivalent to roughly 7.3% of company revenue. Again, it was not 313 million USD of incremental operating profit, but it shows why the stock has a partially financial-market-sensitive earnings component.

The expense side is equally unusual. Incremental direct selling costs related to certain preneed contracts are deferred and recognized as the related performance obligations are fulfilled. SCI recognized 230.9 million USD of those incremental selling costs in 2025. Other selling costs are expensed as incurred. For insurance-funded preneed, general-agency commissions can be recognized at sale while the associated insurance preneed selling costs are expensed as incurred.

That creates real timing gaps between cash flow, GA revenue, sales compensation, deferred expense and eventual funeral revenue. It also explains why stronger preneed sales can occasionally depress current funeral margins: H1 2026 included higher selling compensation associated with increased preneed production even while the underlying future service revenue remained deferred.

The moat has four components that I regard as durable.

The first is local density. SCI can share resources across funeral and cemetery establishments in the same metro area. Combination locations create particularly strong economics because a single family relationship can touch funeral services, cemetery property, merchandise and future preneed selling.

The second is preneed distribution. Building a large salesforce, lead-generation system, compliance infrastructure, trust platform and insurance relationships is costly. A family-owned funeral home can match SCI on compassion or community relationships; it cannot easily match the breadth of the preneed machinery.

The third is financial scale. SCI’s trusts are large enough to access institutional money managers and favorable fee arrangements, and its corporate debt market access allows a continuous acquisition and development program.

The fourth is cemetery land and local licenses. A high-quality cemetery in an established metropolitan area is difficult to recreate because land assembly, zoning, community acceptance, development and decades of heritage all matter.

Brand is a weaker moat. Dignity Memorial gives SCI a national quality umbrella and helps with digital discovery and relocating families, but consumers often buy a specific local funeral home. The fact that SCI continues operating heritage names rather than replacing every sign with one national brand tells the investor where the real customer equity resides.

Management’s capital discipline is generally credible. Tom Ryan has overseen the company through the post-2000 repair, the modern consolidation era, COVID and the current normalization. SCI formally targets leverage of 3.5–4.0 times and a dividend payout of roughly 30–40% of adjusted after-tax earnings, while allocating excess capital among acquisitions, new builds and repurchases.

The weak point is that a 3.5–4.0-times leverage target leaves less room for error than the “non-cyclical” demand profile suggests. Deaths may be stable, but trust markets, refinancing rates and cemetery preneed sales are not.

The broader industry remains heavily fragmented. The national operator sits against thousands of independent funeral businesses, many family owned. That fragmentation creates a long acquisition runway in establishment count, although succession economics and seller valuation matter more than the raw number of independents. SCI has added establishments slowly rather than pursuing another giant roll-up, consistent with management’s claim that it prioritizes acquisitions and new locations only when expected returns exceed its cost of capital.

Demand is defensive, not entirely non-cyclical. Death cannot be postponed because of a recession. Funeral package choice, cemetery property purchases and the timing of preneed commitments can still respond to household finances. Trust returns respond to equity and bond markets. Borrowing costs respond to monetary policy. Cemetery development follows a property-investment cycle. SCI therefore combines a non-discretionary demand base with financial-market, interest-rate and preneed-sales cycles.

Regulation is first-class risk. The FTC Funeral Rule gives consumers the right to itemized prices, limits required purchases, governs direct cremation alternatives and requires telephone and in-person price information. State law separately regulates licensing, preneed sales and trust funding, and SCI is subject to financial and compliance audits of those activities.

The FTC opened an advanced rulemaking process in 2022 around possible changes including mandatory online/electronic pricing, held a workshop in 2023, and in 2024 published results of an undercover telephone-price sweep that found meaningful difficulty and inconsistency in obtaining funeral prices across the industry. The current official Rule page still describes the existing disclosure framework. I found no final nationwide online-price mandate in the FTC material available through the research date, so online disclosure remains a regulatory overhang rather than a completed rule change in this analysis.

Greater online price transparency would not destroy the funeral industry. It could compress one of incumbents’ softer advantages: the difficulty of comparing complex packages during an emotionally stressful purchase. For SCI, the likely effect would be increased pressure to prove service value and greater visibility into price gaps versus independents and direct-cremation alternatives.

SCI also flags unclaimed-property interpretations applied to old preneed balances, cemetery operational claims, general litigation and state trust regulation as material risk categories. Those risks matter because a customer’s relationship with a funeral or cemetery provider is unusually sensitive to errors in handling remains, records, interments and perpetual-care obligations.

Horizontal competitors and current fundamentals

SCI has only one clean U.S.-listed operator comparison today: Carriage Services. Matthews International belongs in the analysis because its Memorialization segment supplies caskets, memorial products and cemetery-related products, but it is not a deathcare-services operator in SCI’s sense. Propel Funeral Partners in Australia and New Zealand is a useful global operating reference. The shrinking public peer set is itself informative: StoneMor was taken private in 2022, Dignity plc left the London market in 2023, and Park Lawn was taken private in 2024 in an approximately C$1.2 billion transaction. Park Lawn’s shares were acquired at C$26.50 apiece.

That thinning peer set suggests public markets have not been the uniquely advantaged owner of deathcare assets. Private insurers and financial sponsors can value the long-duration preneed and cemetery characteristics differently from ordinary equity investors.

Current U.S. market figures highlight SCI’s valuation premium.

Prices and market capitalization in USD.

Carriage Services became the smaller, more concentrated pure-play consolidator. Its Q2 2026 revenue increased only 0.8% to about 102.9 million USD, while comparable funeral volume fell 3.5%; adjusted EBITDA nevertheless increased and margin expanded to 32.3%. The company’s 2026 revenue outlook is roughly 435–445 million USD with a 31–31.5% adjusted EBITDA margin.

CSV therefore confirms that SCI’s current funeral-volume problem is not uniquely an SCI execution problem. Two independent listed operators reported declining comparable funeral volumes in Q2. SCI’s volume decline was milder at 1.4% in the quarter, while Carriage’s was 3.5%.

Carriage is also useful as a valuation control. Its trailing P/E around 12 times is dramatically below SCI’s 21–22 times, while one recent comparative analysis estimated SCI’s EV/EBITDA premium at roughly 51%. Some premium is warranted: SCI has much greater scale, the Dignity network, a broader cemetery base, far larger trusts, easier capital-market access and more diversified geographic exposure. A premium approaching half on enterprise-value multiples means investors are paying for those advantages before they show up as superior near-term volume growth.

Matthews became something quite different. Its Memorialization operation participates in deathcare through caskets, memorial products and cemetery offerings, but the consolidated company also has industrial/product-identification and other businesses. Fiscal Q3 2026 Memorialization sales were approximately 208.1 million USD, while the broader Matthews group was dealing with divestitures, input-cost pressure and execution issues outside deathcare. Its negative trailing earnings make it inappropriate as a direct P/E benchmark for SCI.

Propel Funeral Partners offers the cleaner overseas reference. FY2026 revenue was essentially flat, adjusted operating EBITDA declined 1.6%, and operating EBITDA margin was 24.4%; comparable funeral volume increased about 1.1% while average revenue per funeral increased about 2%. The pattern is familiar: modest death-volume growth plus price, acquisition and mix management rather than technology-style organic growth.

The ecological niche is clear. SCI is the national-scale consolidator and preneed platform in an industry whose customer interface remains local. Carriage is a much smaller consolidator. Propel proves the roll-up concept travels to other fragmented deathcare markets. Matthews earns upstream product economics. Independent local operators remain the primary competitive mass.

Where SCI genuinely wins is not simply “brand.” It can spend more on lead generation, employ specialized preneed salespeople, manage institutional trust pools, finance cemetery development, buy local operators during ownership transitions and spread fixed infrastructure over metropolitan clusters. A family-owned competitor can still beat SCI in a single town through relationships, reputation, price or a respected funeral director.

That explains why SCI has not consolidated the industry into anything resembling a national consumer monopoly despite six decades of acquisition history. The local decision prevents scale from translating one-for-one into customer share.

Current operations reinforce this interpretation.

Q3 2025 was cemetery-led. Revenue increased 4.4% year on year; cemetery preneed sales production increased 9.6%, and adjusted EPS was 0.87 USD. Comparable core funeral average revenue increased, but funeral services performed declined as expected.

FY2025 ended with 4.309 billion USD of revenue, 542.8 million USD of net income and 942.8 million USD of operating cash flow. The cemetery business delivered 1.904 billion USD of revenue and 644 million USD of gross profit.

Q1 2026 retained the same divergence. Revenue was around 1.10 billion USD; net income was about 135.8 million USD. Cemetery activity remained stronger while funeral revenue was pressured by volume. Management nevertheless maintained its full-year guidance.

Q2 improved the consolidated growth rate but did not change the underlying mix. Revenue reached 1.1033 billion USD from 1.0654 billion USD, net income was 124.8 million USD versus 122.9 million USD, and adjusted diluted EPS was 0.90 USD versus 0.88 USD. Comparable funeral services were down 1.4%; average revenue per service rose 3.3%; cemetery preneed sales production rose 8%; funeral preneed sales production rose 7%.

Sources: SCI earnings releases and SEC filings.

The market narrative is therefore more specific than “aging America.” Investors are trading three nearer-term expectations.

First, H2 2026 should be better. Management expects solid revenue growth and margin expansion in both funeral and cemetery versus H2 2025, which supports double-digit second-half EPS growth in its internal framing.

Second, cemetery preneed can continue carrying the growth mix even before national deaths turn upward. That proposition has evidence behind it: Q2 cemetery preneed production rose 8%, after strong growth in several 2025 quarters.

Third, buybacks can keep EPS growing faster than consolidated profit. H1 diluted shares fell from 144.1 million to 139.1 million, and repurchases continued after quarter-end.

The 2026 consensus estimate supports the view that analysts are broadly anchored to management’s range rather than expecting a dramatic beat. Public consensus data show roughly 4.18 USD of EPS for 2026 and 4.59 USD for 2027, compared with management’s 4.10–4.30 USD 2026 range and 4.20 USD midpoint.

A robust free public time series of analyst revisions before and after Q2 was not available in the sources accessed, so I would not claim a broad upward or downward revision cycle. The current consensus itself says the Street is essentially taking management’s 2026 guidance at face value and assuming about 10% further EPS growth in 2027.

The bull case has four evidence-based pillars. Death volumes are likely near the end of the post-pandemic normalization window; cemetery production is already growing without waiting for deaths; preneed backlog continues rising; and share repurchases reduce the denominator.

The bear case also has four. Funeral volumes have been declining despite the demographic narrative; cremation systematically reduces ticket potential; trust investment income has become important enough to make reported growth partially market-dependent; and the stock’s accounting P/E sits above its own long-term norm at a time when risk-free yields are much higher.

Q2’s raised cash guidance sharpens the disagreement.

The cash-flow upgrade is real, but its source makes it less equivalent to an earnings upgrade than a conventional industrial-company cash beat would be. Strong cemetery preneed receipts add liquidity now while much of the economic obligation and revenue recognition remain in the future. That is good business if the contract economics are attractive. It is not free cash detached from future performance obligations.

Valuation, risk, catalysts, and tracking

The current price is 83.36 USD as of the Friday, August 28, 2026 close. Dedicated market data put SCI’s market capitalization near 11.53 billion USD; Google Finance showed a slightly lower 11.36 billion USD figure because of differing share-count timing. I use the dedicated finance-tool market-cap figure in headline calculations and per-share figures where possible.

The accounting-earnings valuation is straightforward. Against management’s 4.20 USD adjusted-EPS midpoint, SCI trades at 19.85 times 2026 adjusted earnings. Trailing databases place the multiple near 21.5–21.8 times, roughly 20% above its 10-year P/E average.

EV/EBITDA is about 12.4 times on current market data. The dividend is 0.36 USD quarterly, or 1.44 USD annualized, for a yield of roughly 1.7%.

Cash passthrough produces a different picture.

Management’s adjusted operating cash-flow midpoint is 1.085 billion USD. Planned capex is 335 million USD: 140 million USD for existing field locations, 170 million USD for cemetery development and 25 million USD for digital/corporate spending. Subtracting all three leaves about 750 million USD.

I regard the 140 million USD as clearly maintenance-like. The 170 million USD cemetery-development figure is economically hybrid: some projects create incremental growth inventory, but SCI must continue developing cemetery property simply to sustain property sales over time. The 25 million USD technology/corporate amount also contains both maintenance and upgrading. For owner-earnings purposes, I deduct the full 335 million USD rather than using a smaller maintenance estimate.

Using current shares, 750 million USD corresponds to owner earnings of roughly 5.4–5.5 USD per share and a price/owner-earnings multiple around 15–15½ times. Depending on whether current basic shares or H1 diluted weighted shares are used, the gap to the 19.85-times forward P/E is roughly 28–31%. It sits right around the framework’s 30% threshold. Because cash timing is the defining accounting issue in this company, I use owner earnings as the primary absolute-valuation basis and P/E as a cross-check.

The owner-earnings yield is approximately 6½%. That is only about 1.8 percentage points above the roughly 4.7% 10-year Treasury yield prevailing on August 28. SCI deserves some growth premium to a Treasury, but an equity investment with leverage, operating risk and trust-market exposure needs more than a nominal 180-basis-point cash-yield spread to qualify as obviously cheap.

At 83.36 USD, SCI is neither a classic expensive growth stock nor an obvious value stock: accounting earnings look rich, while owner earnings look roughly fair.

The absolute valuation below uses a five-year equity-cash-flow model. The starting owner earnings are 750 million USD. Since adjusted operating cash flow already includes interest and tax cash flows, this is treated as cash flow to equity rather than unlevered enterprise cash flow. The discount rate therefore represents required equity return, not WACC.

Author valuation-scenario analysis; starting cash flow is derived from SCI’s 2026 guidance. This is valuation-scenario analysis within a research framework, not investment advice.

The conservative case assumes SCI grows owner earnings only slightly faster than long-run population/death growth and receives no durable premium multiple for management’s historical compounding. It produces value close to, but mostly below, the current quote.

The base case assumes cemetery preneed, modest funeral pricing, targeted acquisitions and buybacks can compound owner earnings around 5% without relying on unusually strong trust markets. That yields a mid-90s value.

The optimistic case requires something closer to management’s historical compounding ambition: funeral volume stops falling, average revenue remains strong, cemetery preneed grows high single digits, trust performance is favorable, buybacks remain accretive and leverage does not force capital retention. That supports value into the 120s/130s.

Historical valuation provides a useful check. A 20-times 2026 EPS multiple appears rich versus the 10-year P/E average near 18 times, but a 15-times owner-earnings multiple is less demanding. The valuation is therefore sensitive to whether an investor believes today’s unusually strong cash conversion represents durable economic earning power or partly a favorable preneed-cash timing window.

Peer valuation leans bearish. Carriage Services trades near 12 times trailing earnings, while SCI is above 21 times; a recent EV/EBITDA comparison estimated SCI’s premium to CSV around 51%. SCI deserves the better multiple, but the comparison prevents a “cheap sector” argument.

The expectation gap is concentrated in H2. At roughly 20 times the EPS midpoint, the market already expects management to deliver its stronger-second-half message. Another quarter of declining funeral volume is tolerable if price, cemetery profit and cash remain strong. A combination of continuing funeral volume decline and weaker cemetery preneed would directly challenge the current multiple.

Trust returns are the second expectation variable. The market does not need trusts to repeat 15% annual investment returns indefinitely. It does need them to earn enough over time to protect the economics of price-guaranteed contracts from service-cost inflation. SCI reported very strong trust returns in 2023–2025, including combined returns around 15.1% in 2025. That is substantially above any prudent long-term assumption and should not be extrapolated.

The third expectation variable is buyback effectiveness. Repurchasing stock at 79 USD when owner-earnings fair value is plausibly in the 90s can create value. Repurchasing aggressively at 100–120 USD while leverage approaches the upper target would do the opposite.

The independent margin-of-safety test is less favorable.

The current price is slightly above the high end of the conservative intrinsic range of 75–82 USD. Therefore the discount to conservative value is zero.

The most fragile base-case assumption is approximately 5% annual owner-earnings growth. Reducing that assumption to 70% of its original level, about 3.5%, drops modeled base value to roughly 90 USD per share. That remains above 83.36 USD, but only by a high-single-digit percentage before allowing for estimation error.

The flat-earnings test is harsher. Assume EPS and valuation are unchanged for three years and the current annual dividend remains 1.44 USD. The shareholder earns only about 1.7% annualized from dividends with no terminal price appreciation. That is far below a 10-year Treasury yield around 4.7%.

Margin-of-safety verdict: none.

That does not mean intrinsic value equals the conservative case. It means the current buyer requires the base or optimistic case to earn an adequate equity return. A price that demands execution is not a margin-of-safety price.

The permanent-loss risks can be narrowed to five.

The first is a sustained trust-asset drawdown combined with service-cost inflation. Probability: medium. Impact: high if prolonged. More than 4.7 billion USD of identified trust assets sits in common-equity-type categories, with additional alternative exposure. A 20–30% broad equity decline would reduce the investment cushion. Most of that decline is not an immediate shareholder loss, but a multi-year shortfall can lower future trust-income recognition and make fixed-price contracts less profitable. The observable indicators are trust fair value versus cost, annual trust return, recognized trust income and any state replenishment requirements.

The second is the funeral volume/cremation squeeze. Probability that cremation continues rising: high. Impact: medium to high. The warning configuration is funeral services declining more than 3% for multiple quarters, average revenue growth falling below roughly 2%, and cremation continuing to increase. That combination would hit funeral gross margin through the fixed-cost base. H1 2026 provided a mild version of that transmission: services declined 3.8% and comparable gross margin fell 220 basis points.

The third is cemetery preneed deceleration. Probability: medium. Impact: high for the current narrative. Cemetery is now the gross-profit leader and a major source of operating cash receipts. If preneed production goes from high-single-digit growth to flat or negative growth, current cash slows first, future backlog replenishment weakens next, and eventual revenue recognition follows later. That would challenge both growth and valuation.

The fourth is leverage/refinancing. Probability: medium. Impact: medium. SCI is at 3.77 times leverage inside a 3.5–4.0-times target. It has ample bank capacity, but 2027 note maturities arrive in a market where risk-free yields are substantially higher than they were when much of the balance sheet was originally financed. The observable warning is leverage above 4.0–4.25 times while interest expense rises faster than EBITDA and repurchases continue.

The fifth is regulatory/reputational loss. Probability of incremental regulation: medium; probability of a catastrophic event: low; impact of a major cemetery/funeral operational scandal can be high. Online price disclosure could increase price competition. State preneed or unclaimed-property changes could alter cash availability. Errors involving remains or interment records can create litigation and brand damage that are far more severe than ordinary service complaints.

Positive catalysts are correspondingly observable. H2 funeral margins can expand as management expects. National mortality can move from normalization toward demographic growth. Cemetery preneed production can remain above 5%. Trust performance can remain positive. Buybacks can continue below intrinsic value. A decline in market interest rates would also make SCI’s cash yield and defensive profile more valuable.

Negative catalysts are the inverse: another guidance year where funeral volume declines 3% or more, cemetery preneed loses momentum, trust returns turn materially negative, cash flow reverts toward accounting income without backlog growth, or leverage rises into a refinancing cycle.

The tracking dashboard below is intentionally small.

Operating references come from SCI; the next-earnings date is a third-party estimate rather than a company-announced date. As of August 30, SCI’s investor-news page had not yet announced the Q3 schedule.

The most useful dashboard relationship is not any one number. Watch funeral volume and average revenue together. Watch cemetery preneed and cash flow together. Watch trust returns and backlog economics together. Watch leverage and buybacks together. A single favorable metric can conceal a deteriorating economic pair.

Cross-synthesis, final conclusion, data, uncertainties, and sources

Looking vertically across six decades, SCI has proven a capability more durable than simple funeral-home acquisition: it can place a corporate capital and sales system above intensely local service businesses without completely destroying the local identity that customers buy.

That capability survived the company’s greatest historical mistake. SCI’s 1990s global expansion proved that the deathcare roll-up thesis can be overleveraged and overextended. The subsequent retreat created the modern model: North American clusters, disciplined local M&A, integrated cemeteries, preneed selling, trusts, insurance funding and recurring capital returns. The present company is stronger because it learned where scale works and where it does not.

The company's proven capability is capitalized localism: centralize financing, trust management, procurement and sales infrastructure while keeping the customer-facing franchise local.

Its past success came from several sources. Industry fragmentation created acquisition opportunities. Cheap capital increased the value of consolidation. Management learned to integrate assets. Cemetery land accumulated over decades. Preneed turned one-time death events into long-duration customer relationships. Buybacks shifted a portion of business growth into per-share growth.

None of those factors was pure luck, although COVID temporarily produced an extraordinary mortality windfall. The fact that SCI retained revenue and cash flow well above 2019 after U.S. deaths normalized supports the view that the post-pandemic earning base is not simply residual excess mortality.

Those success factors mostly remain. Fragmentation still exists. SCI continues finding acquisitions. The trust platform is larger than ever. Cemetery inventory is long-lived. The share count continues falling. North American demographic aging is not reversible over the next decade.

Two success factors have weakened. Cheap capital has gone away, at least for now, and the disposition mix has shifted steadily toward lower-ticket cremation. The first affects the valuation multiple and acquisition financing. The second affects the underlying economics of every incremental death.

The horizontal comparison makes SCI look high quality rather than fast growing. Carriage’s funeral volumes are weak too, which argues against diagnosing SCI’s problem primarily as market-share loss. Propel’s mature deathcare economics in Australia/New Zealand show similarly modest organic growth. The sector itself does not behave like a high-growth consumer category.

SCI’s advantage is that it has more ways to monetize a death or a future death than most competitors. It can sell a funeral, cremation, cemetery property, memorialization, merchandise, preneed planning and insurance-related arrangements. A combination property can connect several. Its trust infrastructure turns a decades-long waiting period into investable assets backing future contractual value.

The weakness is structural rather than temporary: cremation reduces the economic value of an unbundled disposition. SCI must continuously add services and memorialization to maintain the ticket. The current 3.3% increase in average funeral revenue says management is succeeding at that task. The falling funeral margin says the job is unfinished.

The 17.6 billion USD backlog is simultaneously a moat and a source of analytical risk. It makes revenue more predictable because many future customers have already contracted with SCI. It deepens the relationship with families years before need. It also exposes the business to long-duration fulfillment cost, investment returns, regulation and accounting complexity.

A shareholder should never mentally add the backlog to enterprise value. At June 2026 the company reported 17.33 billion USD of associated assets against 17.62 billion USD of future revenue. The economics belong partly to contract holders, partly to third-party insurers and partly to SCI’s eventual delivery margin.

Q2 2026 provides a miniature stress test of how investors can misread the business. Funeral volume fell, revenue rose, EPS edged higher and cash flow surged. All four facts are true. The correct causal chain is cemetery production plus pricing plus trust income plus lower share count plus favorable cash timing, not a sudden acceleration in deaths.

That makes management’s H2 promise unusually important. If funeral and cemetery margins both expand against H2 2025 while cemetery preneed remains strong, SCI will show that H1’s funeral weakness was a temporary normalization within a functioning compounding model. If funeral margin remains compressed despite easier comparisons, the market will have to lower its estimate of the profit that can be extracted from each death.

Over one year, the variables are H2 margin recovery, funeral volume, cemetery preneed sales, trust income and cash conversion.

Over three years, the key issue becomes the bridge from underlying business growth to EPS. Deaths may grow only around 1% annually. SCI therefore needs price/mix, cemetery, acquisitions and share retirement to build the rest of the return. A company that can consistently turn 4–6% economic growth into 7–10% per-share cash growth deserves a premium. A company that uses leverage and expensive repurchases to manufacture the same arithmetic does not.

Over five years, demographics become more supportive. The oldest baby boomers will be approaching their late 80s and national deaths should be on a structurally rising path. The Census has projected annual U.S. deaths rising substantially as the population ages. The upside, however, comes with an offsetting disposition transition: a larger share of those deaths will end in cremation.

This is where I think the standard market narrative is most likely to be wrong. “More deaths” does not automatically mean proportional funeral revenue growth. The relevant variable is revenue and profit per death after cremation mix.

The cemetery business is the answer management has built to that problem. Cremation does not eliminate memorialization. A cremated individual can still generate a niche, memorial, service, scattering garden or other cemetery revenue. The large cemetery footprint therefore gives SCI more ways to retain economics as disposition preferences change.

The cemetery model also introduces property risk. High preneed production can pull cash forward. Development spending must follow. Backlog grows. Revenue comes out later. If an investor focuses exclusively on current cash flow, the company can look more asset-light than it is.

The current market valuation rewards much of SCI’s proven history. At 20 times guided EPS, the market is not treating the company like a slow-growth utility. The historical P/E comparison confirms a premium to the 10-year center.

Owner earnings prevent that conclusion from becoming too bearish. A 6½% post-capex cash yield is respectable, particularly for a company with defensive end demand and plausible mid-single-digit long-term cash growth. The problem is the alternative return. A 10-year Treasury near 4.7% means the incremental expected return for owning SCI’s leverage, trust-market exposure and operational risk is not large under the conservative case.

The current market price spends some of SCI’s future demographic and capital-allocation success before the funeral-volume recovery is visible.

Section 10.1: Bull and bear reasons.

Bull reasons:

• Q2 cemetery preneed production grew 8%, while 2025 cemetery gross profit already exceeded funeral gross profit, so SCI has a current growth engine that does not require funeral volume to recover immediately.
• The preneed backlog reached 17.62 billion USD at June 30, 2026, providing an unusually large reservoir of contracted future relationships and revenue.
• 2026 adjusted operating cash-flow guidance was raised to a 1.085 billion USD midpoint, implying about 750 million USD after the entire planned 335 million USD capex program.
• H1 diluted share count declined 3.5% year on year, and SCI retained 567.5 million USD of repurchase authorization at June 30, giving management a meaningful per-share-growth mechanism.

Bear reasons:

• H1 2026 comparable funeral services declined 3.8% and funeral margin fell from 22.2% to 20.0%, showing that fixed-cost deleverage can overwhelm 3% price growth.
• SCI’s cremation rate reached 64.8% and continues rising, while national cremation is projected above 80% by 2045; every mix shift raises the burden on memorialization and price.
• Q2 recognized trust income increased 22.5 million USD year on year, making a significant part of marginal growth sensitive to investment markets rather than operating volume.
• Current P/E is roughly 20% above the 10-year historical average while the 10-year Treasury yields about 4.7%, leaving little conservative valuation cushion.

Section 10.2: Pre-mortem.

The first concrete 50%-loss script begins with financial markets rather than deaths. Assume 2027–2028 delivers a 25–30% equity-market drawdown and weak bond returns, reducing the trust-asset cushion. Funeral services remain down 2% annually, cremation approaches 67–68%, and SCI can raise average revenue only 2%. Cemetery preneed slows to low single digits as household confidence weakens. Owner earnings falls from roughly 750 million USD toward 600 million USD while leverage moves above 4.2 times because management has continued acquisitions and repurchases. EPS retreats toward 3.4–3.6 USD. A market that had paid roughly 20 times guided EPS rerates the stock to 13–14 times. A 3.4 USD EPS figure at 13 times is 44 USD, a decline of approximately 47% from 83.36 USD. The permanent damage comes from low trust returns plus higher fulfillment costs plus leverage, not the temporary stock-market drawdown alone. Supporting exposure data come directly from SCI’s trust and leverage disclosures.

The second script begins with consumer economics. By 2028, low-cost direct cremation providers and independent funeral operators use mandatory or voluntarily expanded online price transparency to make package comparison easier. SCI’s cremation mix rises toward 68%, average funeral revenue growth slips to 1%, and funeral gross margin falls from around 20–21% into the high teens. Cemetery preneed remains positive but cannot fully offset the funeral profit loss. EPS stagnates around 3.5 USD while the equity risk premium rises and SCI rerates to 14 times earnings. That produces about 49 USD per share. Add a coincident trust-market drawdown and the low-40s become plausible. The mechanism does not require deaths to decline; it requires profit per death to decline. FTC scrutiny of funeral-price disclosure makes this a testable regulatory scenario rather than an abstract competition story.

Section 10.3: Final research conclusion.

SCI is one of the unusual businesses where “boring” demand hides sophisticated finance. The company has genuine advantages: local density, cemetery land, institutional trust management, a large preneed sales machine and disciplined share retirement. The 2026 results also show a management team adapting to the industry's structural problem. Funeral volume is weak, but price, cemetery economics, trust income and capital allocation continue carrying consolidated performance.

The quality of the business does not automatically make 83.36 USD an attractive entry price. At roughly 20 times guided EPS, SCI is above its historical valuation center. Its 6½% estimated owner-earnings yield looks considerably better, but a roughly 4.7% Treasury yield reduces the compensation for taking equity, leverage, trust and execution risk. The present quote sits inside my acceptable-hold range and only slightly above the conservative intrinsic-value band, yet it has no independent margin of safety under the framework’s stricter test.

I would change that judgment in either direction through operating evidence rather than price momentum. A sustained return of funeral volumes to flat or positive growth, cemetery preneed above 5%, funeral margin recovery and leverage below 4 times would raise confidence that mid-single-digit owner-earnings growth can persist. Funeral declines below -3% for several quarters, cemetery preneed stagnation, a sustained trust shortfall or leverage moving above 4.25 times would lower the earnings-growth assumptions before any change in valuation multiple.

Company-profile scores:

• Fundamental quality: high
• Growth: medium
• Moat: medium
• Financial soundness: medium
• Management credibility: high
• Valuation attractiveness: low
• Risk level: medium
• Suitable investor type: value

Investment rating:

• Rating: Hold
• One-line thesis: Cemetery preneed and buybacks offset funeral-volume erosion, but roughly 20x guided EPS and a 4.7% Treasury yield leave no conservative margin of safety.
• Ideal buy price:

【Ideal Buy Price】60–65 USD

Basis: the 75–82 USD conservative intrinsic-value range discounted by at least 20%. This is the only buy-range basis used in the report.

• Acceptable hold price: 82–110 USD, corresponding approximately to ±15% around the 92–96 USD base-case fair-value area.
• Clearly overvalued price: 138–150 USD, beginning roughly 10% above the 125–136 USD optimistic intrinsic-value range.
• Current-price classification: acceptable hold.
• Whether to wait for a better price: yes. A new purchase becomes materially more attractive at 60–65 USD if comparable funeral volume has stabilized, cemetery preneed growth remains at least mid-single-digit and leverage remains no higher than 4.0 times. The opportunity cost of waiting is the roughly 1.7% dividend yield, continued buyback accretion and the possibility that H2 execution causes intrinsic value to compound faster than the entry-price threshold.
• Target holding horizon: 3–5 years.
• Expected annualized return: roughly 0–1% in the conservative case, about 6% in the base case and approximately 16–18% in the optimistic case over three years, including approximate dividends and assuming convergence toward the respective valuation ranges.
• Max-loss risk: approximately 45–50% in the combined pre-mortem case where owner earnings and EPS fall, trust economics deteriorate, leverage rises and the earnings multiple contracts to 13–14 times.
• Reassessment-trigger signals: comparable funeral services below -3% for two consecutive quarters; funeral gross margin below 19% for two quarters; cemetery preneed production at or below zero growth for two quarters; leverage above 4.25 times; or a material trust-replenishment requirement emerging from sustained asset underperformance.

Rating: Hold. The asymmetry is presently modest: SCI can compound attractively if the base case works, but the current price does not compensate an investor for the conservative case failing.

【Valuation Range】

• current: 83.36 (close as of 2026-08-28)
• bear (conservative · ideal buy zone): [60, 65]
• base (fair · acceptable hold zone): [82, 110]
• bull (optimistic · above the clearly-overvalued line): [138, 150]

Research uncertainties.

The first blind spot is exact current demographic forecasting. The latest Census projection framework provides annual projected deaths through 2100, but the web-accessible representation available in this research session did not expose the numeric rows of the downloadable table. I therefore use current CDC mortality figures and the Census’s official directional projections, including the older official 3.6-million-by-2037 figure, rather than inventing a more precise 2026–2036 CAGR. The defensible planning conclusion is roughly 1% annual death-count growth over the coming decade, not several percent.

The second is acquisition multiples. SCI discloses annual acquisition spending and establishment counts but not enough target EBITDA to calculate a reliable average tuck-in EV/EBITDA. Any precise “SCI buys funeral homes at X times EBITDA” figure would require private transaction information not established by the primary evidence here.

The third is segment ROIC. Public reporting does not allocate taxes, corporate cost, debt and trust-backed capital sufficiently to produce a clean after-tax funeral versus cemetery ROIC. Gross-profit/asset and net-capital proxies show why cemetery is more property-intensive, but they should not be mistaken for audited segment ROIC.

The fourth is analyst-estimate revision history. Current consensus is available, but a reliable free timestamped dataset showing every post-Q2 estimate revision was not found. I therefore compare current consensus with management guidance rather than claim a revision trend that cannot be verified.

The fifth is the timing of Q3 2026 results. A third-party calendar currently estimates October 26, 2026; SCI itself had not published the Q3 schedule in the investor-news feed as of August 30. Treat the date as expected, not confirmed.

Core sources used.

SCI’s quarter ended June 30, 2026 Form 10-Q is the controlling source for the backlog, trust portfolio, debt, leverage, share count and repurchase figures.

SCI’s July 29, 2026 earnings release is the controlling source for Q2 operating results, revised cash guidance, adjusted EPS guidance and management’s current second-half framing.

SCI’s FY2025 Form 10-K and associated disclosures are the main source for segment economics, preneed accounting, trust-income recognition, selling-cost accounting and 2023–2025 cash-flow comparisons.

SCI’s corporate history and historical SEC filings support the vertical reconstruction of the founder era, 1969 public-company transition and late-1990s global scale.

CDC/NCHS mortality data provide the post-pandemic death-count baseline.

The U.S. Census Bureau provides the demographic projection framework and long-run direction of annual deaths.

The FTC provides the controlling federal Funeral Rule and current regulatory-development evidence.

NFDA provides current U.S. cremation-rate estimates and long-run disposition projections.

Current SCI, CSV and MATW market prices are from dated market feeds for August 28, 2026.

U.S. Treasury and contemporaneous bond-market data provide the risk-free-rate valuation cross-check.

Other tickers mentioned

• CSV.US: Carriage Services is SCI’s closest currently listed U.S. funeral-and-cemetery operating comparable.
• MATW.US: Matthews International’s Memorialization segment is an upstream deathcare reference but not a direct operating peer.
• PFP.AU: Propel Funeral Partners is a listed Australia/New Zealand pure-play reference for funeral-volume, pricing and consolidation economics.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.